RE:RE:RE:RE:RE:RE:RE:Donnatal Efficacy?Thanks for the link. I read the letter to the FDA and their response/ The auther says the FDA denied request for delay which is not true. What else is fictional in the article? Below my response to comments made in the article by the author.
Not sure why you say the FDA had denied Concordia request for delay the process when the lawyers said they would provide info by June 30, 2015 and FDA said they should provide in writing if " if the additional data submission to these dockets is
completed before June 30,2015." This is not in any way a denial by the FDA to allow Concordia a delay in providing information. Anyway, this is more than a year ago - what has transpired since then? It seems you are a very late to the party as it were and your interpretation of events is highly questionable at best. Donnatal is still available to be prescribed at this time so the FDA requirements have been satisfied I presume?
LatticeInExiIe wrote: adamchess, Here is the article that summarizes why Donnatal is at risk. The author has sourced the article with letters from the FDA, as well as letters from Concordia's lawyers as a response, as well as numerous other documents explaining that the drug is up for DESI review. Please refrain from saying that this is made up by the shorts because you will just look like a silly investor who doesn't do their due diligence. If posters continue saying that this risk is made up without offering any substantial support for their claim, I will continue to post this seeking alpha article throughout the weekend.
https://seekingalpha.com/instablog/47547305-the-capitolist/4903656-concordia-international-key-us-product-donnatal-extreme-regulatory-risk-may-put-business-risk adamchess wrote: Why is Concordia being asked about the efficiency of Donnatel when this product has existed for ages? Surely, it has been found to significantly benefit customers or it would have been tossed out years ago. The whole attack by shorts makes no sense. Sales force was increased recently to boost sales of this product.